NR-52281SARS相关冠状病毒2,隔离USA-WA1/2020(病毒）
产品图片
货号/SKU
NR-52281
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、3
产品描述信息
NR-52281??SARS-Related Coronavirus 2, Isolate USA-WA1/2020(Viruses)|SARS-Related Coronavirus 2|Isolate USA-WA1/2020|-60°C or colder|CDCAcknowledgment for publications should read “The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52281.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
This virus was originally deposited to BEI Resources as 2019 Novel Coronavirus, but subsequently named SARS-CoV-2 by the International Committee on Taxonomy of Viruses (ICTV). Please note that the depositor’s original nomenclature was used on the product label.
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate USA-WA1/2020 was isolated from an oropharyngeal swab from a patient with a respiratory illness who had recently returned from travel to the affected region of China and developed clinical disease (COVID-19) in January 2020 in Washington, USA.
Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate USA-WA1/2020 is assigned lineage A and GISAID clade S using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome of SARS-CoV-2, USA-WA1/2020 has been sequenced (the isolate - GenBank: MN985325 and GISAID: EPI_ISL_404895 and after one passage in Vero cells - GenBank: MT020880). The complete genome of SARS-CoV-2, USA-WA1/2020 has been sequenced after four passages in Vero cells in collaboration with Database for Reference Grade Microbial Sequences (FDA-ARGOS; GenBank: MT246667). BioProject PRJNA716271, Sequencing of SARS-CoV-2 Isolates from BEI Resources, has been published on the NCBI website. The sequences from the BEI Resources SARS-CoV-2 isolates included in the project have been deposited into GenBank (SRA: SRP312598) and the sequence for SARS-CoV-2, isolate USA-WA1/2020 (NR-52281), is available (SAMN18527778).
Each vial contains approximately 0.5 mL of cell lysate and supernatant from Cercopithecus aethiops kidney cells infected with SARS-CoV-2, isolate USA-WA1/2020.
Additional information and tools are available at ViPR (Virus Pathogen Resource).
This virus was originally deposited to BEI Resources as 2019 Novel Coronavirus, but subsequently named SARS-CoV-2 by the International Committee on Taxonomy of Viruses (ICTV). Please note that the depositor’s original nomenclature was used on the product label.
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate USA-WA1/2020 was isolated from an oropharyngeal swab from a patient with a respiratory illness who had recently returned from travel to the affected region of China and developed clinical disease (COVID-19) in January 2020 in Washington, USA.
Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate USA-WA1/2020 is assigned lineage A and GISAID clade S using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome of SARS-CoV-2, USA-WA1/2020 has been sequenced (the isolate - GenBank: MN985325 and GISAID: EPI_ISL_404895 and after one passage in Vero cells - GenBank: MT020880). The complete genome of SARS-CoV-2, USA-WA1/2020 has been sequenced after four passages in Vero cells in collaboration with Database for Reference Grade Microbial Sequences (FDA-ARGOS; GenBank: MT246667). BioProject PRJNA716271, Sequencing of SARS-CoV-2 Isolates from BEI Resources, has been published on the NCBI website. The sequences from the BEI Resources SARS-CoV-2 isolates included in the project have been deposited into GenBank (SRA: SRP312598) and the sequence for SARS-CoV-2, isolate USA-WA1/2020 (NR-52281), is available (SAMN18527778).
Each vial contains approximately 0.5 mL of cell lysate and supernatant from Cercopithecus aethiops kidney cells infected with SARS-CoV-2, isolate USA-WA1/2020.
Additional information and tools are available at ViPR (Virus Pathogen Resource).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
该病毒最初存放到2019年新型冠状病毒的Bei资源，但随后由国际病毒（ICTV）的国际委员会命名为SARS-COV-2. 请注意，存款人的原始命名用途是在产品标签上使用.
急性急性呼吸综合征相关的冠状病毒2（SARS-COV-2），分离出美国-WA1 / 2020从患有最近从旅行到中国受影响的地区返回的呼吸系统疾病和临床的患者疾病（Covid-19）在美国华盛顿的1月20日.
在GISAID引入的命名系统（全球共享所有流感数据），SARS-COV-2，使用命名的全球爆发谱系（Pangolin）工具的系统发育分配分配了谱系A和GISAID CLADE S的SARS-COV-2. SARS-COV-2的完整基因组已被测序（孤立 - Genbank：
mn985325 和gisaid：epi_isl_404895和在Vero celler中的一段经过 - genbank：mt020880 ）. SARS-CoV-2的完整基因组，USA-WA1 / 2020在与参考级微生物序列的数据库合作的vero细胞中的四次通道后已经测序（FDA-Argos; Genbank： mt246667 ）. bioproject prjna716271 ，
SARS-COV-2的测序来自BEI资源，已发表于
NCBI网站.来自BEI资源SARS-COV-2分离的序列
该项目中已包含在GenBank（SRA：）
和SARS-COV-2的顺序，隔离USA-WA1 / 2020（NR-52281）是
可用（ samn18527778 ）.
每个小瓶含有大约0.5ml的细胞裂解物和来自 Cercopithecus Aethiops的肾细胞感染SARS-CoV-2的肾细胞，分离USA-WA1 / 2020.
vipr （病毒病原体资源）提供了附加信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2021-12-21
2021-12-21
2021-12-13
2024-05-19
2022-03-31
2024-05-19
2024-01-15
2024-02-26
2022-04-01
2022-01-10
2022-04-01
2021-12-21
2025-03-11
2024-05-19
2021-12-21
2021-12-21